These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15364949)

  • 21. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
    Kobayashi H; Narita Y; Nishida M; Kurose H
    Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77.
    Castro-Obregón S; Rao RV; del Rio G; Chen SF; Poksay KS; Rabizadeh S; Vesce S; Zhang XK; Swanson RA; Bredesen DE
    J Biol Chem; 2004 Apr; 279(17):17543-53. PubMed ID: 14769794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nerve growth factor stimulation of p42/p44 mitogen-activated protein kinase in PC12 cells: role of G(i/o), G protein-coupled receptor kinase 2, beta-arrestin I, and endocytic processing.
    Rakhit S; Pyne S; Pyne NJ
    Mol Pharmacol; 2001 Jul; 60(1):63-70. PubMed ID: 11408601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
    Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
    Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
    Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells.
    Quoyer J; Longuet C; Broca C; Linck N; Costes S; Varin E; Bockaert J; Bertrand G; Dalle S
    J Biol Chem; 2010 Jan; 285(3):1989-2002. PubMed ID: 19915011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells.
    Waters CM; Connell MC; Pyne S; Pyne NJ
    Cell Signal; 2005 Feb; 17(2):263-77. PubMed ID: 15494217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
    Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells.
    Yamakawa T; Tanaka S; Yamakawa Y; Kamei J; Numaguchi K; Motley ED; Inagami T; Eguchi S
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):752-8. PubMed ID: 12006386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.
    Montezano AC; Burger D; Paravicini TM; Chignalia AZ; Yusuf H; Almasri M; He Y; Callera GE; He G; Krause KH; Lambeth D; Quinn MT; Touyz RM
    Circ Res; 2010 Apr; 106(8):1363-73. PubMed ID: 20339118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of G protein-coupled receptor kinase 4 and beta-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases.
    Iacovelli L; Salvatore L; Capobianco L; Picascia A; Barletta E; Storto M; Mariggiò S; Sallese M; Porcellini A; Nicoletti F; De Blasi A
    J Biol Chem; 2003 Apr; 278(14):12433-42. PubMed ID: 12519791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
    Chiou WF; Tsai HR; Yang LM; Tsai WJ
    Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
    McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
    Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by β-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1.
    Law IK; Murphy JE; Bakirtzi K; Bunnett NW; Pothoulakis C
    J Biol Chem; 2012 Apr; 287(18):15066-75. PubMed ID: 22416137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
    Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
    J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
    Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.
    Broca C; Quoyer J; Costes S; Linck N; Varrault A; Deffayet PM; Bockaert J; Dalle S; Bertrand G
    J Biol Chem; 2009 Feb; 284(7):4332-42. PubMed ID: 19074139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
    Singh M; Moniri NH
    Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".
    Jafri F; El-Shewy HM; Lee MH; Kelly M; Luttrell DK; Luttrell LM
    J Biol Chem; 2006 Jul; 281(28):19346-57. PubMed ID: 16670094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.